0000940394-16-002686.txt : 20160616 0000940394-16-002686.hdr.sgml : 20160616 20160616154024 ACCESSION NUMBER: 0000940394-16-002686 CONFORMED SUBMISSION TYPE: 497K PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160616 DATE AS OF CHANGE: 20160616 EFFECTIVENESS DATE: 20160616 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EATON VANCE GROWTH TRUST CENTRAL INDEX KEY: 0000102816 IRS NUMBER: 042325690 FILING VALUES: FORM TYPE: 497K SEC ACT: 1933 Act SEC FILE NUMBER: 002-22019 FILM NUMBER: 161717553 BUSINESS ADDRESS: STREET 1: TWO INTERNATIONAL PLACE CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-482-8260 MAIL ADDRESS: STREET 1: TWO INTERNATIONAL PLACE CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: EATON VANCE GROWTH FUND INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: VANCE SANDERS COMMON STOCK FUND INC DATE OF NAME CHANGE: 19820915 FORMER COMPANY: FORMER CONFORMED NAME: BOSTON STOCK FUND INC DATE OF NAME CHANGE: 19730619 0000102816 S000005202 Eaton Vance Worldwide Health Sciences Fund C000014191 Eaton Vance Worldwide Health Sciences Fund Class A ETHSX C000014192 Eaton Vance Worldwide Health Sciences Fund Class B EMHSX C000014193 Eaton Vance Worldwide Health Sciences Fund Class C ECHSX C000014194 Eaton Vance Worldwide Health Sciences Fund Class R ERHSX C000081646 Eaton Vance Worldwide Health Sciences Fund Class I 497K 1 wwhsf_supp61616.htm GT WORLDWIDE HEALTH SCIENCES FUND SUPPLEMENT DTD 6-16-2016 Worldwide Health Sciences Fund Pro and SP Supp dtd 5-26-16 Proxy

EATON VANCE WORLDWIDE HEALTH SCIENCES FUND

Supplement to Prospectus dated January 1, 2016 and

Summary Prospectus dated January 1, 2016



A special meeting of shareholders was held today, June 16, 2016, where the following proposals were approved:

an Investment Advisory Agreement between Eaton Vance Management (“EVM”) and Worldwide Health Sciences Portfolio (“Portfolio”), the Portfolio in which Eaton Vance Worldwide Health Sciences Fund invests substantially all of its assets, pursuant to which EVM will serve as investment adviser to the Portfolio;

an Investment Sub-Advisory Agreement between EVM and Eaton Vance Management (International) Limited (“EVMI”), pursuant to which EVMI will serve as investment sub-adviser to the Portfolio; and

a Research Support Agreement between EVM and OrbiMed Advisors LLC (“OrbiMed”), pursuant to which OrbiMed will serve as investment sub-adviser to the Portfolio providing research services to EVM with respect to the Portfolio’s investment program.

The foregoing agreements are expected to be effective on or about July 1, 2016.  As of such date, EVM will appoint Jason Kritzer and Samantha Pandolfi of EVM and EVMI, respectively, as portfolio managers of the Portfolio.  


June 16, 2016

22317   6.16.16